Ex-Neuralink President Invests in Competing Brain Startup

New York-based Synchron Inc.—a competitor to Elon Musk’s brain-machine interface company, Neuralink—has won financial backing from Neuralink’s co-founder and former president.

Max Hodak, who left Neuralink last year, has invested in Synchron and joined its advisory board, he wrote in a blog post on Friday. He did not say how much he was investing.

“I jumped at the chance to work with them,” he wrote, saying the company’s technology could benefit tens of millions of patients. Synchron aims to treat conditions like paralysis by inserting its Stentrode implant in human brains. That is similar to Neuralink, which also plans to use ...